Stock IRAA IRIS ACQUISITION CORP
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Iris Acquisition Corp

Equities

IRAA

US89601Y1010

Market Closed - Nasdaq
Other stock markets
 21:30:01 25/06/2024 BST 		5-day change 1st Jan Change
11.67 USD +0.78% Intraday chart for Iris Acquisition Corp +5.61% +12.97%
05-23 Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-17 Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Iris Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)
AQ
IRIS ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
IRIS ACQUISITION CORP : Change in Directors or Principal Officers (form 8-K)
AQ
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
IRIS ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)
AQ
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp
AQ
Iris Acquisition : Businesses announce Definitive Business Combination Agreement and plan to operate under Liminatus Pharma - Form 8-K
PU
IRIS ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments
BU
IRIS ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
IRIS ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
IRIS ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Tribe Capital Growth I : Announces Name Change to Iris Acquisition Corp and Other Management Changes - Form 8-K
PU
IRIS ACQUISITION CORP : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TRIBE CAPITAL GROWTH CORP I : Other Events (form 8-K)
AQ
TRIBE CAPITAL GROWTH CORP I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IRAA Stock
  4. News Iris Acquisition Corp
  5. Press Releases